Our finding of a potential link between astrocyte phenotype (GFAP upregulation and hypertrophic morphology) and stroke protection raises a tantalizing possibility that Smad1 ablation in the CNS may mimic the well-known preconditioning effect in raising the baseline levels of astrocyte reactivity. Here, GFAP is linked to stroke disorder.